Abstract:ObjectiveTo investigate the effect of thymopentin combined with chemotherapy on T lymphocyte subsets in peripheral blood of patients with multiple myeloma.Methods24 patients with multiple myeloma diagnosed in our hospital from July 2016 to July 2017 were selected and randomly divided into chemotherapy group chemotherapy+thymopentin group,12 cases in each group.In the chemotherapy group,tad (thalidomide+epirubicin+dexamethasone)was used as the main chemotherapy regimen for 4 consecutive courses.In the chemotherapy plus thymopentin group,TAD was the main chemotherapy regimen and thymopentin was added for 4 consecutive courses.Total T cells(CD3+),helper/inducible t cells(CD4+),inhibition/cytotoxic T cells(CD8+)ratio and CD4+/CD8+ratio in peripheral blood lymphocytes were measured by flow cytometry before and after treatment.ResultsThere was no significant difference in cellular immune function between the two groups before chemotherapy(P>0.05).CD3+,CD4+positive percentage and CD4+/CD8+ratio of chemotherapy+thymopentin group were higher than those before chemotherapy and chemotherapy alone (P<0.05).The total effective rate of chemotherapy+thymopentin group was higher than that of chemotherapy group (P<0.05).Conclusions Thymopentin combined with chemotherapy can improve the immune function of patients with multiple myeloma,improve the effective rate,reduce the infection rate.
胡婷; 彭丽萍 ;张琛晓. 胸腺五肽联合化疗对多发性骨髓瘤患者外周血T淋巴细胞亚群的影响[J]. 中国当代医药, 2018, 25(5): 74-76.
HU Ting; PENG Li-ping ;ZHANG Chen-xiao. Effect of thymopentin combined with chemotherapy on T lymphocyte subsets in peripheral blood of patients with multiple myeloma. 中国当代医药, 2018, 25(5): 74-76.